To compare the mental health experiences associated with coronavirus disease 2019 (COVID-19) in adults with and without diabetes.

Between 29 May 2020 and 30 June 2020, 2,176 U.S. adults completed an online survey including demographics, COVID-19 experiences, depression (eight-item Patient Health Questionnaire) and anxiety (seven-item Generalized Anxiety Disorder) symptoms, perceived stress (17-item Diabetes Distress Scale), resilience (Brief Resilience Scale), and diabetes-related distress (in participants with diabetes).

Mean age was 49.6 years (SD 16.9); participants were primarily women (80.0%) and White (88.3%), with an annual household income of ≥$60,000 (57.6%). One hundred reported a diagnosis of type 1 diabetes (4.6%), 304 type 2 diabetes (13.9%), and 145 prediabetes (6.6%). Nearly one-third (29.7%) indicated decreases in income attributable to the pandemic. Participants with type 1 diabetes had higher levels of diabetes distress than participants with type 2 diabetes (P < 0.05), with moderate severity in both groups. Participants with type 2 diabetes had significantly more comorbidities and COVID-19 risk factors than all other groups (all P < 0.01). After controlling for covariates, participants with type 2 diabetes reported significantly more depressive symptoms than those without diabetes (P < 0.05) and lower levels of resilience (P < 0.05). Subgroup analyses by sex and age indicated that women and younger adults, particularly those age 18–34 years, reported significantly more depression and anxiety symptoms, stress, and diabetes-related distress and lower levels of resilience than men and adults age ≥51 years.

In this naturalistic observational study, participants with type 2 diabetes reported more depression, lower resilience, and significantly more COVID-19 risk factors and medical comorbidities than participants without diabetes. Overall, our participants demonstrated worse depression and anxiety symptoms during compared with before the pandemic.

比较患有和未患有糖尿病的成年人与 2019 年冠状病毒病 (COVID-19) 相关的心理健康经历。

在 2020 年 5 月 29 日至 2020 年 6 月 30 日期间，2,176 名美国成年人完成了一项在线调查，包括人口统计、COVID-19 经历、抑郁症（八项患者健康问卷）和焦虑症（七项广泛性焦虑症）症状、感知压力 (17-项目糖尿病痛苦量表）、复原力（简要复原力量表）和糖尿病相关痛苦（糖尿病参与者）。

平均年龄为 49.6 岁（标准差 16.9）；参与者主要是女性（80.0%）和白人（88.3%），家庭年收入≥60,000 美元（57.6%）。100 人报告诊断为 1 型糖尿病（4.6%）、304 例 2 型糖尿病（13.9%）和 145 例糖尿病前期（6.6%）。近三分之一（29.7%）的人表示收入因大流行而减少。1 型糖尿病患者的糖尿病困扰程度高于 2 型糖尿病患者（P < 0.05），两组患者的严重程度均为中度。与所有其他组相比，2 型糖尿病参与者的合并症和 COVID-19 危险因素明显更多（均P < 0.01）。在控制协变量后，患有 2 型糖尿病的参与者报告的抑郁症状明显多于没有糖尿病的参与者。P < 0.05) 和较低水平的复原力 ( P < 0.05)。按性别和年龄进行的亚组分析表明，与男性和 51 岁以上的成年人相比，女性和年轻人，尤其是 18-34 岁的人，报告的抑郁和焦虑症状、压力和糖尿病相关的痛苦和复原力水平显着降低。

在这项自然主义的观察性研究中，与没有糖尿病的参与者相比，患有 2 型糖尿病的参与者报告了更多的抑郁症、更低的复原力以及更多的 COVID-19 风险因素和医学合并症。总体而言，与大流行前相比，我们的参与者表现出更严重的抑郁和焦虑症状。